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Abstract
Atrial fibrillation (AF) often occurs in the presence of an underlying disease. These underlying diseases cause atrial remodelling, which make the
atria more susceptible to AF. Stretch is an important mediator in the remodelling process. The aim of this study was to develop an atrial cell cul-
ture model mimicking remodelling due to atrial pressure overload. Neonatal rat atrial cardiomyocytes (NRAM) were cultured and subjected to
cyclical stretch on elastic membranes. Stretching with 1 Hz and 15% elongation for 30 min. resulted in increased expression of immediate early
genes and phosphorylation of Erk and p38. A 24-hr stretch period resulted in hypertrophy-related changes including increased cell diameter,
reinduction of the foetal gene program and cell death. No evidence of apoptosis was observed. Expression of atrial natriuretic peptide, brain
natriuretic peptide and growth differentiation factor-15 was increased, and calcineurin signalling was activated. Expression of several potassium
channels was decreased, suggesting electrical remodelling. Atrial stretch-induced change in skeletal a-actin expression was inhibited by pra-
vastatin, but not by eplerenone or losartan. Stretch of NRAM results in elevation of stress markers, changes related to hypertrophy and dediffer-
entiation, electrical remodelling and cell death. This model can contribute to investigating the mechanisms involved in the remodelling process
caused by stretch and to the testing of pharmaceutical agents.
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Introduction
Atrial fibrillation is the most common cardiac arrhythmia [1] and it
often occurs because of an underlying disease, such as hypertension
or heart failure [2]. Structural remodelling seen in patients with AF as
well as in animal models includes atrial dilatation, cellular hypertro-
phy, dedifferentiation, fibrosis, apoptosis and myolysis [3–7]. Electro-
physiological changes also occur and may contribute to the
progressive nature of AF [4, 8]. The underlying disease is a major
causal factor of atrial remodelling [5–7, 9–15]. The common factor in
these underlying disease states is haemodynamic and pressure over-
load of the ventricles and the atria which causes stretching. However,
it is difficult to determine in animal models whether the critical mech-
anism is mechanical stress or neurohormonal activation. In vitro,
stretching of ventricular cardiomyocytes has been associated with
hypertrophy, increased calcineurin activity, apoptosis and release of
reactive oxygen species [16–18]. Stretching of atrial cells, however,
is not well characterized. Atria from hypertensive animals show
increased weight, fibrosis and inflammation [11, 13, 15] and long-
term hypertension (4–5 years) results in enlarged atria, hypertrophy,
fibrosis, dedifferentiation, cell death and myolysis, but without any
sign of inflammation [5]. In in vitro experiments, static stretch leads
to electrical remodelling, hypertrophy, increased calcineurin activity
and extracellular matrix remodelling [19–21]. Static stretch, however,
may not reflect the physiological situation.
In an effort to better simulate the clinical setting of atrial pressure
overload, our objective was to develop an atrial cell culture model
mimicking atrial remodelling due to atrial pressure overload.
Materials and methods
Ethics statement
All animal studies were conducted in accordance with the NIH Guide for
the Care and Use of Laboratory Animals and approved by the Commit-
tee for Animal Experiments of the University of Groningen (Approval ID:
DEC 5495 and DEC 6002).
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Isolation and culture of neonatal rat atrial
cardiomyocytes
Neonatal rat atrial cardiomyocytes (NRAM) were isolated and cells were
cultured, as described previously [22]. Briefly, the hearts of 1- to 3-
day-old Sprague Dawley rats were excised and transferred in a tube
containing cold calcium- and bicarbonate-free Hanks with Hepes solu-
tion (CBFHH) (137 mmol/l NaCl, 5.36 mmol/l KCl, 0.81 mmol/l MgSO4,
5.55 mmol/l dextrose, 0.44 mmol/l KH2PO4, 0.34 mmol/l Na2HPO4 and
20 mmol/l HEPES, pH 7.4). Atria and ventricles were then separated
and atrial cardiomyocytes were isolated by successive rounds of stirring
and pipetting the tissue up and down in CBFHH supplemented with
1.5 mg/ml trypsin (BD Biosciences, Breda, the Netherlands) and 20 lg/
ml DNase. To enrich the cardiomyocytes, the cell suspension was pre-
plated on regular polystyrene dishes for 45 min. and the cardiomyo-
cytes were then seeded on flexible collagen-coated silicone rubber
membranes (Flexcell International Corporation, Hillsborough, NC, USA)
coated with 0.1% gelatin at a density of 62500 cells/cm2.
Cardiomyocytes were cultured for 24 hrs at 37°C under 5% CO2 in
MEM and supplemented with sodium bicarbonate for 5% CO2,
25 mmol/l Hepes (Invitrogen Corporation, Breda, the Netherlands),
1.5 mmol/l vitamin B12, 5% FCS, 0.1 mmol/l BrdU and penicillin-strep-
tomycin (50 U/ml and 50 mg/ml, respectively; Invitrogen Corporation).
The cells were then cultured in the same medium without serum and
BrdU, but supplemented with transferrin (10 lg/ml), insulin (10 lg/ml)
and bovine serum albumin (BSA; 1 mg/ml) for 18–48 hrs before the
experiments were carried out.
Inhibitors were incubated with the cells for 30 min. prior to the
stretch period. Concentrations used were: 1 lmol/l losartan, 1 lmol/l of
the selective Ca2+/calmodulin-dependent protein kinase II (CaMKII)
inhibitor KN93, 1 lmol/l cyclosporin A (Merck, Darmstadt, Germany),
10 lmol/l eplerenone and 10 lmol/l pravastatin.
Application of mechanical stretching
Cardiomyocytes were stretched using the Flexercell-4000 system (Flexcell
International Corporation), a modification of the system initially described
by Banes et al. [23]. Cyclical stretching of 1 Hz and 15% elongation was
applied for different durations ranging from 30 min. to 24 hrs. Control
cardiomyocytes were cultured on identical Flexerwell plates and main-
tained under similar conditions, but without mechanical stretch. Following
the stretch periods, the cells were washed twice with PBS and used for
protein analysis, immunofluorescence or RNA isolation.
Cell diameter
Cells were fixed in 4% paraformaldehyde for 5 min. on ice, permeabi-
lized with ice-cold PBS + 0.3% Triton X100 for 5 min. and then washed
with PBS. A solution containing 3% BSA, 2% normal goat serum and
0.1% tween in PBS was used to block and reduce the background. Anti-
bodies were diluted in 1% BSA in PBS and incubated with the cells for
1 hr at room temperature. The primary antibody was a mouse monoclo-
nal anti-a-actinin (clone EA-53) and the secondary antibody was a goat
antimouse FITC (Santa Cruz Biotechnology, Heidelberg, Germany).
Counterstaining with fluorescent rhodamine-phalloidin (Invitrogen Cor-
poration) was performed to differentiate non-cardiomyocytes. Coverslips
were mounted using Vectashield mounting medium with DAPI (Vector
Laboratories, Burlingame, CA, USA). Four to eight pictures were taken
and 5–10 cells/picture were used per experiment. Image processing
software (Image J 1.43u, NIH, Bethesda, MD, USA) was used to deter-
mine Feret’s cell diameter. Cell diameter was expressed as a percentage
of the diameter of control cells.
Real-time quantitative PCR
Total RNA was isolated using TRIzol reagent (Invitrogen Corporation) or
Nucleospin II kit (Macherey-Nagel, D€uren, Germany) and converted to
cDNA by QuantiTect Reverse Transcription (Qiagen, Venlo, the Nether-
lands). Gene expression was measured with Absolute QPCR SYBR
Green ROX Mix (Abgene, Epsom, UK) in the presence of 7.5 ng cDNA
and 200 nM forward and reverse primers. qRT-PCR was performed on
the Biorad CFX384 (Bio-Rad, Veenendaal, the Netherlands). The initial
denaturation and activation of the DNA polymerase (95°C for 3 min.)
was followed by 35 cycles with denaturation for 15 sec. at 95°C and
annealing and elongation for 30 sec. at 60°C followed by a melt curve.
Gene expression levels were corrected for ribosomal protein, large, P0
(Rplp0) reference gene expression and values were expressed relative
to the respective control group of each experiment. Primers used
included: jun proto-oncogene (c-jun) forward gatcatccagtccagcaatg,
c-jun reverse tattctggctatgcagttcag, FBJ osteosarcoma oncogene (c-fos)
forward tccaagcggagacagatcaac, c-fos reverse tggcaatctcggtctgcaa,
myelocytomatosis oncogene (c-myc) forward ctagtgctgcatgaagagac, c-
myc reverse ttgctgtggcctcttgatgg, early growth response gene 1 (egr-1)
forward gcacctgaccacagagtcctt, egr-1 reverse ggtagtttggctgggataacttg,
atrial natriuretic peptide (ANP) forward atgggctccttctccatcac, ANP
reverse tctaccggcatcttctcctc, brain natriuretic peptide (BNP) forward
acaatccacgatgcagaagct, BNP reverse gggccttggtcctttgaga, growth differ-
entiation factor-15 (GDF15) forward tgacccagctgtccggatac, GDF15
reverse gtgcacgcggtaggcttc, a-myosin heavy chain (MHC) forward gac-
aactcctcccgctttgg, aMHC reverse aagatcacccgggacttctc, bMHC forward
gtcaagctcctaagtaatctgtt, bMHC reverse gaaaggatgagcctttctttgc, skeletal
a-actin (ACTA1) forward gggcaggtcatcaccatc, ACTA1 reverse tac-
aggtccttcctgatgtc, sodium channel, voltage-gated, type V, alpha subunit
(Scn5a) forward ctgctcgtcatggtcattgg, Scn5a reverse tgaggttgtctgcgct-
gaag, a1c subunit of L-type Ca2+-channel (LTCC) forward ccggaagc-
cagtgcatttt, LTCC reverse gttggtgaagatcgtgtcattgac, potassium voltage-
gated channel, Shal-related subfamily, member 3 (Kcnd3) forward
gccttgccagaatccgtgtg, Kcnd3 reverse gacgtggtcttgcccatgtg, potassium volt-
age-gated channel, KQT-like subfamily, member 1 (Kcnq1) forward gtttg
aacagggtggaagac, Kcnq1 reverse tcatcactggctacgacttg, potassium inwardly
rectifying channel, subfamily J, member 2 (Kcnj2) forward
gcaatgccggagttcatatc, Kcnj2 reverse tgctaagtctctggcactac, inwardly rectify-
ing channel, subfamily J, member 3 (Kcnj3) forward tgcgcaacagcca-
catggtc, Kcnj3 reverse cacgtggcaaatggtgagag, potassium intermediate/
small conductance calcium-activated channel, subfamily N, member 1
(Kcnn1) forward ccggactgtgaagattgaac, Kcnn1 reverse ctcatatgc-
gatgctctgtg, solute carrier family 8 (sodium/calcium exchanger), member
1 (Ncx1) forward attgaagcgatcaccgtcag, Ncx1 reverse ggacgaaggcaaaca-
gaacc, regulator of calcineurin 1 (Rcan1) forward agcgaaagtgagaccagggc,
Rcan1 reverse ggcagggggagagatgagaa, Ca2+/calmodulin-dependent protein
kinases IId (CaMKIId) forward aaacgcatcacagcctctga, CaMKIId reverse
gaggcaacagtagaacgttgaca, angiotensin II receptor type 1a forward cac-
aaccctcccagaaagtg, angiotensin II receptor type 1a reverse tagagggtaggga-
tcatgac, ras-related C3 botulinum substrate 1 (Rac1) forward
aacctgcctgctcatcagtt, Rac1 reverse ttgtccagctgtgtcccata [24], inducible
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nitric oxide synthase (iNOS) forward ggaagaaatgcaggagatgg, iNOS reverse
gcaggatgtcttgaacgtag, endothelial nitric oxide synthase (eNOS) forward
tcctaacttgccttgcatcc, eNOS reverse ggcagccaaacaccaaagtc, Rplp0 forward
gttgcctcagtgcctcactc and Rplp0 reverse gcagccgcaaatgcagatgg.
Western blotting
Proteins from whole cell lysates were isolated using radioimmuno-pre-
cipitation assay buffer [0.5% sodium deoxycholate, 0.1% sodium dode-
cylsulfate (SDS) and 1% Igepal ca-630 in TBS] supplemented with a
protease inhibitor cocktail (Roche Diagnostics Corp., Indianapolis, IN,
USA), a phosphatase inhibitor cocktail, PMSF (1 mmol/l; Roche Diag-
nostics Corp.) and sodium vanadate (15 mmol/l). SDS sample buffer
was added and samples were denaturized by heat at 99°C for 5 min.
Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel,
transferred to PVDF membranes (Bio-Rad) and blocked with 5% milk in
0.1% tween in TBS (TBST). Blots were incubated overnight with anti-
bodies against either phospho-Erk (E-4), troponin T-C (C-19) (both
Santa Cruz Biotechnology), troponin I-C (MF4; Fitzgerald Industries
International, Acton, MA, USA), phospho-Akt (Ser473) (D9E), phospho-
p38 (Thr180/Tyr182; both Cell Signaling Technology, Danvers, MA,
USA) or microtubule-associated protein light chain 3 (LC3; MBL, Naka-
ku Nagoya, Japan) diluted in either 5% milk or BSA in TBST. For
loading control, membranes were reprobed with a-tubulin or GAPDH
antibodies (Fitzgerald Industries International). For loading phosphory-
lated proteins controls, the membranes were stripped (stripping buffer
containing 2% SDS, 100 mmol/l b-mercaptoethanol and 62.5 mmol/l Tris
buffer) for 30 min. at 55°C, washed with TBST and incubated with the
corresponding antibody detecting the total protein amount, i.e. Erk 1/2
(MK1; Santa Cruz Biotechnology) and Akt (C67E7) and p38 (both Cell
Signaling Technology). Signals were detected by ECL and quantified by
densitometry (Syngene, Cambridge, UK). Protein levels were expressed
relative to the respective control group of each experiment.
ANP in cell culture medium
The level of ANP secreted into the medium was measured using a com-
petitive enzyme immunoassay kit (Bachem, St. Helens, Merseyside, UK)
according to the manufacturer’s instructions. Samples were measured
in duplicate and the levels of ANP were expressed as a percentage of
ANP released by stationary cardiomyocytes.
Cell death
To investigate whether apoptosis occurred, the terminal deoxynucleo-
tidyl transferase (TdT)-mediated dUTP Nick End Labelling method
(TUNEL) was used according to the manufacturer’s instructions (Roche
Diagnostics Corp.). Coverslips were mounted using Vectashield with
DAPI (Vector Laboratories). To confirm that the TUNEL-labelled positive
cells were cardiomyocytes, a counterstaining with a-actinin was per-
formed, as described above.
To determine the amount of dead cells released into the cell culture
medium, medium was taken together with PBS from two washes to
include cells that were no longer fully attached. Cells were spun down,
washed in PBS, collected in 200 ll PBS and counted (in duplicate)
using a counting chamber (Fuchs-Rosenthal, Lo – Laboroptik Ltd.,
Lancing, UK). The amount of cells released into the medium was
expressed relative to the amount of cells in the medium of stationary
cells. Trypan blue staining was used to confirm that the majority of cells
in the medium were dead cells.
In addition, lactate dehydrogenase (LDH) levels were determined in
duplicate in cell culture medium using the Roche IFCC liquid assay on
the modular analysis (Roche, Mannheim, Germany).
Reagents and chemicals
Unless otherwise stated, all chemicals were purchased from Sigma-
Aldrich Chemie B.V. (Zwijndrecht, the Netherlands).
Statistics
Data are expressed as mean values  S.E.M. Comparisons between
groups were done using one-way ANOVA with post-hoc Dunnett correc-
tion. For Figure 5b, a Bonferonni correction was used. Comparison of
two groups was done using a two-tailed Student’s t-test. All analyses
were carried out using PASW (Version 18, SPSS Inc., Chicago, IL,
USA). P values of <0.05 were considered statistically significant.
Results
Immediate early genes
Stretch for 30 min. increased the mRNA expression of the immediate
early genes c-fos by 647%, c-jun by 212%, c-myc by 56% and early
growth response gene 1 (egr-1) by 465% (Fig. 1a). In addition, phos-
phorylation levels of Erk and p38 were increased 68% and 101%
respectively (Fig. 1b–d).
Hypertrophy and dedifferentiation
Stretch for 24 hrs increased the cell diameter by 10% (P < 0.05,
Fig. 2a and b) along with troponin T and troponin I expression by
51% (P < 0.05) and 42% (P < 0.05), respectively, (Fig. 2c and d)
suggesting hypertrophy-related increase in contractile protein expres-
sion. To investigate the dedifferentiation that often accompanies path-
ological hypertrophy, mRNA expression of skeletal a-actin, a-MHC
and b-MHC were investigated. After 24 hrs of stretch, the b/a-MHC
ratio and skeletal a-actin expression were increased by 41% and 76%
respectively (Fig. 2e and f).
Stress markers
Stretch of NRAM caused a biphasic release of ANP (Fig. 3a), signifi-
cantly different from control at 30 min., 1 hr, 24 and 48 hrs (increased
by 43, 53, 44 and 102% respectively). Furthermore, 24 hrs of stretch
increased mRNA levels of ANP by 47% (Fig. 3b). The biphasic
ª 2013 The Authors
Journal of Cellular and Molecular Medicine Published by Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
745
J. Cell. Mol. Med. Vol 17, No 6, 2013
response, with increased ANP mRNA expression, implies immediate
release of ANP upon stretch, subsequent increased ANP production
and a second phase of release of ANP. After 3 hrs of stretch, BNP
mRNA expression levels were increased by 99% (Fig. 3c). Levels
remained 70% increased after 6 and 24 hrs of stretch and the
expression level of GDF15 was increased 77% after 24 hrs (Fig. 3d).
Cell death
Three different forms of cell death exist: apoptosis, cell death with
autophagy and necrosis. TUNEL staining showed 6.1% TUNEL-
positive cells in control cells compared with 6.2% following stretch
(Fig. 4a). Western blotting for LC3-II, a marker of autophagosomes
(a double-membrane structure which contains elements of its own
cytoplasm mediating autophagy), revealed no difference between
control cells and stretched cells (Fig. 4d and e). Although no sign
of cell death was shown by TUNEL staining or LC3-II Western blot-
ting, a 78% increase (Fig. 4b) in the amount of cells in the med-
ium was observed after 24 hrs of stretch. As a positive control for
cell death, staurosporine was used; staurosporine increased the
amount of cells in the medium 170% (Fig. 4b). Trypan blue stain-
ing was used to confirm that the cells released in the medium
were indeed dead cells. The majority of the cells (95%) stained
blue, showing that these cells did not have an intact cell mem-
brane. In addition, LDH levels were threefold increased in medium
from stretched cells (Fig. 4c) Also, a trend towards increased
phosphorylation of Akt, a protein involved in cellular survival path-
ways, was observed (Fig. 4d and f).
Electrical remodelling
Figure 5 shows the effects of 24 hrs of stretch on genes related to
electrical remodelling. Stretch for 24 hrs had no effect on expres-
sion of Scn5a which contributes to the sodium current (INa), expres-
sion of LTCC which contributes to the L-type calcium current (ICaL)
or expression of the sodium/calcium exchanger (Ncx1; Fig. 5).
Stretch reduced expression levels of Kcnd3 to 30% of control levels.
Kcnd3 encodes Kv4.3 and contributes to the cardiac transient out-
ward potassium current (Ito). Also expression of Kcnq1, Kcnj2 and
Kcnj3 were reduced to 63, 63 and 75% of control levels, respec-
tively. Kcnq1 encodes Kv7.1 and mediates slow delayed rectifying K
+
(IKs), Kcnj2 codes for Kir2.1 and mediates the inward rectifier cur-
rent (IK1) and Kcnj3 codes for Kir3.1 and mediates acetylcholine-
activated inward rectifier K+ current (IKACh). Interestingly, also the
expression of small conductance Ca2+-activated K+ channel 1 (SK1)
was reduced.
Mechanisms
Stretch for 24 hrs increased the expression of Rcan1 by 124%
(Fig. 6a) suggesting the involvement of calcineurin signalling. Fur-
thermore, treatment with 1 lM cyclosporine A was associated with a
trend towards attenuation of the stretch-induced increase in the
expression of skeletal a-actin (Fig. 6b). This suggests activation of




Fig. 1 Stretching for 30 min. induces
immediate early genes expression and
phosphorylation of Erk and p38. (A)
Expression of c-fos, c-jun, c-myc and egr-
1 upon stretching (n = 7). (B) Represen-
tative blots showing phosphorylated and
total Erk and p38 levels after 30 min. of
stretch. (C) Relative levels of phosphory-
lated Erk (n = 8). (D) Relative levels of
phosphoryated p38 (n = 7). Data are
expressed relative to control. *P < 0.05,
**P < 0.01, compared with unstretched
control. Egr-1: early growth response pro-
tein 1; Rplp0: ribosomal protein, large,
P0; C: control; Str: stretch.
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We could not demonstrate the involvement of CaMKII in the
stretch-activated response as no increase in expression of CaMKIId,
the major CaMKII isoform in the heart, was observed after 24 hrs of
stretch (Fig. 6c) and inhibition of CaMKII with 1 lM KN93 did not
alter the expression level of skeletal a-actin (Fig. 6b).
Interventions
Treatment with losartan had no effect on the gene expression of skel-
etal a-actin (Fig. 6d) which suggests that this response is not medi-
ated via ligand activation of the angiotensin II type 1 receptor.
However, the expression of the angiotensin II receptor type 1a was
decreased (Fig. 6c). Incubation with eplerenone had no effect on
stretch-induced gene expression, but pravastatin reduced stretch-
induced expression of skeletal a-actin (Fig. 6e). No effect of stretch
on expression of Rac1 was observed (Fig. 6f), but the expression of
eNOS and iNOS was reduced (Fig. 6f).
Discussion
This study shows that cyclic stretch of NRAM results in (1) activation
of immediate early genes, distinct signalling pathways, changes
related to hypertrophy and dedifferentiation, elevation of stress mark-





CFig. 2 Stretching causes changes associ-
ated with hypertrophy and dedifferentia-
tion. (A) Atrial myocytes were stained for
a-actinin with specific antibodies (green)
and actin was stained with Texas Red-
phalloidin. Nuclei are stained blue with
DAPI. (B) Relative cell diameter after
24 hrs of stretching (n = 11). (C) Relative
protein levels of troponin I and troponin T
(n = 18 and 19, respectively). (D) Repre-
sentative blots showing levels of troponin
I and troponin T after stretching for
24 hrs. (E) b/a-MHC ratio (n = 7–19). (F)
Skeletal a-actin expression (n = 8–19).
Data are expressed relative to control.
*P < 0.05, **P < 0.01, ***P < 0.001
compared with unstretched control. C:
control; Str: stretch; b/a-MHC: b/a-myo-
sin heavy chain; ACTA1: skeletal a-actin;
Rplp0; ribosomal protein, large, P0.
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signalling, but not of CaMKII signalling; (3) inhibition of skeletal a-
actin expression with pravastatin and (4) the demonstration that BNP
in atrial cells is a stronger stress marker than ANP in neonatal atrial
cardiomyocytes in vitro.
Activation of immediate early genes is an early response to a wide
variety of growth factors, cytokines as well as injury. Previous studies
in isolated rat atria showed that stretch increased the expression of c-
fos, c-myc and egr-1, but not of c-jun [25, 26] which is in agreement
with our study. In ventricular cells, activation of immediate early
genes has also been demonstrated in response to stretch [27, 28].
Kerkela et al. showed a rapid increase in phosphorylated p38 and Erk
due to stretch which is in agreement with our data showing that
30 min. of stretch increased phosphorylation levels of p38 and Erk
[26]. Similar findings have also been reported in stretched ventricular
cardiomyocytes [17, 29].
In atrial cardiomyocytes subjected to stretch, hypertrophy was
suggested via an increase in protein to DNA ratio and ANP mRNA
levels [19, 20]. We also observed an increase in cell length, tropo-
nin expression and the expression levels of ANP, which is often
used as a marker of hypertrophy. In animal models of hyperten-
sion, enlarged atria have also been observed [5, 11, 13, 15, 30–
32], as well as atrial dedifferentiation, in models of hypertension,
mitral valve disease and atrial fibrillation [5, 32, 33] which is in
agreement with the increased levels of gene expression markers of
dedifferentiation we observed in our study. An important aspect of
dedifferentiation is myolysis, which has been described in cells sub-
jected to tachypacing and in patients with AF [34], but has not been
described in association with stretch. Reduced expression of tropo-
nins was found in AF patients, which correlated with the amount of
myolysis [35]. We, however, did not observe any reduction in tro-
ponin protein levels which suggests that stretch for 24 hrs is a
model in which remodelling takes place without the loss of contrac-
tile elements.
GDF15 is a potential new biomarker and a 25-fold increased
expression has been observed in stretched ventricular myocytes [36].
In our experimental model, we only observed a 1.8-fold increase in
expression. This discrepancy may be due, at least in part, to the dif-
ferent stretch protocols used (cyclic versus static).
Cell death has not been described in stretched atrial cardio-
myocytes. In hypertensive sheep, atrial apoptosis has been dem-
onstrated [5], but in a dog model of mitral regurgitation, no sign
of necrosis was found [31]. We observed an increase in cell death
which probably did not occur via apoptosis because there was no
increase in TUNEL-positive cells. In addition, no protective effect
of the autophagosome was found (unchanged protein levels of
LC3-II).
Electrical remodelling has been described extensively related to
AF [37, 38]. In cells, Yang et al. showed that rapid electrical stimula-
tion of HL-1 cells induced electrical remodelling, including shortening
of action potential duration [39]. In patients with hypertension, elec-
trical remodelling has also been described [9]. More recently, also
SK1 and SK2 were recognized to play a role in electrical remodelling
in AF [40]. In atrial cardiomyocytes stretch also been related to elec-
trical remodeling. Saygili et al. found a reduced Ito and a reduced
expression of Kv4.2, in addition, an increased IK1 and an increased
expression of Kir2.1 and Kir2.3 was observed [19]. These findings are
partially in agreement with ours; we observed a reduced expression
of Kv4.3 and also a reduced expression of Kir2.1.
A B
C D
Fig. 3 Stretching increases mRNA expres-
sion of stress specific markers and
induces release of ANP. (A) ANP release
into the medium (n = 3–9). (B) ANP
expression (n = 8–21). (C) BNP expres-
sion (n = 8–20). (D) GDF15 expression
(n = 8–19). Data are expressed relative to
control. *P < 0.05, **P < 0.01, and
***P < 0.001 compared with unstretched
control. ANP: atrial natriuretic peptide;
BNP: brain natriuretic peptide; GDF15:
growth differentiation factor-15; Rplp0:
ribosomal protein, large, P0.
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Many changes in calcium handling and Ca2+-dependent mecha-
nisms are related to atrial remodelling [41]. Static atrial stretch has
been shown to increase calcineurin activity and Rcan1 expression
[20]. Furthermore, cyclosporine A, a calcineurin inhibitor, reduced
stretch-induced changes in extracellular matrix remodelling in atrial
cardiomyocytes [21]. Our observations are in agreement with these
previous studies. We observed a stretch-induced increased Rcan1
mRNA expression, and cyclosporine A tended to attenuate the
increase in skeletal a-actin expression. In AF, down-regulation of the
expression of the L-type Ca2+-channel has been observed [42]. Simi-
larly, reduced atrial L-type Ca2+-current has been demonstrated in
patients with mitral valve disease or reduced ejection fraction [43].
However, we did not observe any reduction in L-type Ca2+-channel
expression after 24 hrs of stretch.
In an atrial cardiomyocytes model of static stretch, losartan atten-
uated the stretch-induced hypertrophy and electrical and extracellular
matrix remodelling [19, 21]. In our experiments, losartan had no
effect on stretch-induced increase in skeletal a-actin expression. We
did, however, observe a down-regulation of the angiotensin II type 1
receptor which might be protective. An important difference between
these studies and ours is the type of stretch used. In our experimental
model, we used a similar elongation, but a cyclical stretch pattern
which, as opposed to static stretch, mimics a more physiological con-
dition. Furthermore, we could not show protective effects of eplere-
Fig. 5 Changes in gene expression related to electrical remodelling.
Effect of 24 hrs stretch on gene expression of Scn5a, LTCC, Kcnd3,
Kcnq1, Kcnj2, Kcnj3, Kcnn1 and NCX1 (n = 9–11). Data are expressed
relative to control. *P < 0.05, **P < 0.01 and ***P < 0.001 compared
with unstretched control. Scn5a, sodium channel, voltage-gated, type V,
alpha subunit; LTCC, a1c subunit of L-type Ca2+-channel; Kcnd3, potas-
sium voltage-gated channel, Shal-related subfamily, member 3; Kcnq1,
potassium voltage-gated channel, KQT-like subfamily, member 1; Kcnj2,
potassium inwardly rectifying channel, subfamily J, member 2; Kcnj3,
inwardly rectifying channel, subfamily J, member 3; Kcnn1, potassium
intermediate/small conductance calcium-activated channel, subfamily N,
member 1; Ncx1, solute carrier family 8 (sodium/calcium exchanger).
A B C
D E F
Fig. 4 Stretching for 24 hrs induces cell death, but not via apoptosis or autophagy. (A) The amount of TUNEL-positive cells after 24 hrs of stretch-
ing (n = 11). (B) The relative amount of cells in the medium after stretching (n = 9–10). (C) The amount of LDH in the medium (n = 6). (D) Repre-
sentative blots showing levels of LC3-II after 24 hrs of stretching and levels of phosphorylated and total Akt after 30 min. of stretching. (E) Relative
protein levels of LC3-II (n = 10). (F) Relative levels of phosphorylated Akt (n = 8). Data are expressed relative to control. *P < 0.05, **P < 0.01,
and ***P < 0.001 compared with unstretched control. PC: positive control, staurosporine (500 nM 24 hrs); LC3: microtubule-associated protein
light chain 3.
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none, but pravastatin prevented the stretch-induced increase in skele-
tal a-actin expression. This suggests a role for reactive oxygen spe-
cies which has not been described in atrial cells. However, in
ventricular myocytes, stretch has been shown to induce the release of
reactive oxygen species and these reactive oxygen species mediated
the effect of stretch [17, 44]. Rac1 is a small GTPase that regulates
the activity of NAPDH oxidase, producing superoxide. Increased
expression of Rac1 has been implicated in AF [45]. However, we did
not observe changes in the expression of Rac1, but we did observe
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As expected, ANP expression, a key factor in cardiac stress, was
increased upon stretch. We observed a comparable small increase in
ANP mRNA levels as previously described in atrial cardiomyocytes
[19, 20]. Increased expression of BNP has also been found following
atrial stretch [26]. In human atrial strips, BNP is also induced by
ischaemia; this is independent of mechanical stress [46]. In our
experiments, changes in BNP mRNA levels were more pronounced
than changes in ANP expression levels. Our findings confirm that
atrial cardiomyocytes are a source of BNP and show, in vitro, that
stretch induced BNP expression. Interestingly, our results suggest
that during stretch, BNP is a better stress marker than ANP in neona-
tal atrial cardiomyocytes in vitro.
In summary, we have demonstrated that cyclical stretch of atrial
cardiomyocytes results in activation of immediate early genes and
distinct signalling pathways including phosphorylation of Erk and
p38, changes related to hypertrophy and dedifferentiation, elevation
of stress markers such as ANP, BNP and GDF15, changes related to
electrical remodelling and cell death (Fig. 6g). Previous studies dem-
onstrated that static stretch results in hypertrophy [19, 20], increased
MMP2 and MMP9 activity [21] and changes in potassium currents
and gene expression suggesting electrical remodelling [19, 20]. We
observed the involvement of calcineurin, but not of CaMKII signalling.
Incubation with losartan or eplerenone was without effect, but pra-
vastatin reduced skeletal a-actin expression upon stretch. The role of
calcineurin [20, 21] and angiotensin II-dependent signalling pathways
has been suggested in previous studies [19, 21]. Importantly, our
results were obtained using cyclical stretch, a context reflecting more
adequately the physiological condition where the pressure in the
atrium increases during each heart cycle.
In ventricular cardiomyocytes, more data are available on the
effects of in vitro stretch [16–18, 27, 28, 36, 47]. In ventricular car-
diomyocytes another method of stretch, using glass microspheres to
induce mechanical load, did not induce hypertrophy, but did induce
arrhythmias and caused the release of angiogenic factors [48].
Results obtained using ventricular cardiomyocytes cannot be directly
extrapolated because atrial and ventricular cardiomyocytes are ana-
tomically and functionally different and express genes to a different
extent [49, 50]. In a microarray performed by Barth et al., differences
in gene expression were shown between human atria and ventricles
[51]. In the atria, genes associated with fibrosis, apoptosis and neu-
rohormonal activation were more highly expressed whereas, in the
ventricles, genes associated with the contractile function were more
abundant [51].
Limitations
We used cyclical stretch as a model of atrial overload caused by dis-
ease states that create a substrate for AF. It is not known whether the
mechanisms described in our experimental model could be extrapo-
lated to humans. We tested a limited number of mechanisms and sig-
nalling pathways that are often activated in ventricular disease as well
as mechanisms that have been described in atrial fibrillation. It is
likely that other signalling pathways are also activated, but this war-
rants further investigation. In vitro, stretch of atrial and ventricular
cardiomyocytes can be dissected. In vivo, however, atrial fibrillation
results in a high ventricular rate which has been shown to be an
important causal factor of atrial remodelling [6, 10].
Conclusions
The present stretch model resulted in changes mimicking the situa-
tion caused by underlying disease. Our model used cyclical stretch of
the atrial cardiomyocytes and provides useful data on different
aspects of remodelling. This model can be used to investigate mecha-
nisms involved in the remodelling process as well as to assess the
effect of new pharmaceutical agents on the remodelling process.
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Fig. 6Mechanisms involved in the stretching response. Effect of 24 hrs of stretching on (A) Rcan1 expression (n = 19). (B) The effect of 1 lmol/l
KN93 and 1 lmol/l cyclosporin A on the stretch-induced increase in skeletal a-actin expression (n = 7–18). (C) Expression levels of CaMKIId
(n = 11), and expression of angiotensin II receptor type 1a (n = 8). (D) The effect of 1 lmol/l losartan and 10 lmol/l eplerenone on the stretch-
induced increase in expression of skeletal a-actin (n = 5–18). (E) The effect of 10 lmol/l pravastatin on the expression of skeletal a-actin (n = 7).
(F) Expression levels of Rac1, eNOS and iNOS (n = 9). (G) Overview of stretch-activated mechanisms. Data in A, C and G are expressed relative to
control, in B, D, E and F data are expressed relative to unstretched control with 0.1% DMSO. *P < 0.05, **P < 0.01 and ***P < 0.001 compared
with unstretched control and in Figure C, D, E and F compared with stretch with DMSO. Rcan1: regulator of calcineurin 1; Rplp0: ribosomal protein,
large, P0; ACTA1: skeletal a-actin; GDF15: growth differentiation factor-15; DMSO: dimethyl sulfoxide; CsA: cyclosporin A; Epl: eplerenone; Los: lo-
sartan; Prava: pravastatin; CaMKII: Ca2+/calmodulin-dependent protein kinases IId; AIIR type 1a: angiotensin II receptor type 1a; Rac1: ras-related
C3 botulinum substrate 1; eNOS: endothelial nitric oxide synthase; ANP: atrial natriuretic peptide; BNP: brain natriuretic peptide; b/a-MHC: b/a-myo-
sin heavy chain; Egr-1: early growth response protein 1.
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